Journal of Pharmaceutics & Pharmacology

Menu

Drug Delivery

Dr. Vinayagam Kannan

Scientist

Par Sterile Products, LLC, USA

E-mail: vinayagampk@yahoo.com

Repurposing of adamantanes for the potential prevention or treatment of COVID-19

Butterworth Roger F,

Professor of Medicine,

University of Montreal, Canada

E-mail: rb@enceph.com

S2: Repurposing of Adamantanes for the Potential Prevention or Treatment of COVID-19

Potential for the Repurposing of Adamantanes for the Treatment of Covid-19

Authors: Roger F Butterworth

DOI: 10.13188/2327-204X.S200001

( Downloads 32 Views 32)

Repurposing of Adamantanes for the Treatment of COVID-19: Rationale and Perspectives

Authors: Butterworth Roger F

DOI: 10.13188/2327-204X.S200002

( Downloads 13 Views 13)

The Sars-Cov-2 Viroporin E and its Interaction with Amantadine an Analysis

Authors: Aranda-Abreu GE, Hernández-Aguilar ME, Herrera-Covarrubias D and Rojas-Durán F

DOI: 10.13188/2327-204X.S200003

( Downloads 12 Views 12)

Lysosomotropic Action of Amantadine: Basis for Treatment of COVID-19

Authors: Smieszek SP, Przychodzen BP and Polymeropoulos MH

DOI: 10.13188/2327-204X.S200004

( Downloads 8 Views 8)

Repurposing of Adamantanes with Transmitter Receptor Antagonist Properties for the Prevention/Treatment of COVID-19

Authors: Brenner SR and Butterworth RF

DOI: 10.13188/2327-204X.S200005

( Downloads 10 Views 10)

Amantadine for the Treatment of SARS-Cov-2: Case Report

Authors: Aranda-Abreu GE1, Aranda-Martínez JD and Araújo R

DOI: 10.13188/2327-204X.S200006

( Downloads 11 Views 11)

Adamantanes for the Prevention of COVID-19: A Review of Case Reports

Authors: Cortes Borra A

DOI: 10.13188/2327-204X.S200007

( Downloads 17 Views 17)